Literature DB >> 27492118

Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM.

Naveen Pemmaraju1, Audun Utengen2, Vikas Gupta3, Jean-Jacques Kiladjian4, Ruben Mesa5, Michael A Thompson6.   

Abstract

The social media platform Twitter has provided the hematology/oncology community with unprecedented, novel methods of interpersonal communication and increased ability for the dissemination of important updates in a rapidly moving field. The advent, and subsequent success, of disease-specific Twitter communities have further enabled interested healthcare stakeholders to become quickly organized around a unique set of rare medical conditions, such as hematologic malignancies, that, historically, generally lack large amounts of reliable online information. One example is the Twitter community #MPNSM (myeloproliferative neoplasms on social media), which was started approximately one and half years ago and has served as a recognized venue for discussion among many members of the MPN community, including patients, researchers, providers, and advocacy organizations. This article will focus on understanding the impact of the founding of this community via the analysis of advanced Twitter metrics of user experience, from the first year of use for this novel healthcare hashtag.

Entities:  

Keywords:  Disease-specific hashtag; Myelofibrosis; Myeloproliferative neoplasm; Polycythemia vera; Social media; Twitter

Mesh:

Year:  2016        PMID: 27492118     DOI: 10.1007/s11899-016-0341-2

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  18 in total

Review 1.  Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.

Authors:  Brady L Stein; Jason Gotlib; Murat Arcasoy; Marie Huong Nguyen; Neil Shah; Alison Moliterno; Catriona Jamieson; Daniel A Pollyea; Bart Scott; Martha Wadleigh; Ross Levine; Rami Komrokji; Rebecca Klisovic; Krishna Gundabolu; Patricia Kropf; Meir Wetzler; Stephen T Oh; Raul Ribeiro; Rita Paschal; Sanjay Mohan; Nikolai Podoltsev; Josef Prchal; Moshe Talpaz; David Snyder; Srdan Verstovsek; Ruben A Mesa
Journal:  J Natl Compr Canc Netw       Date:  2015-04       Impact factor: 11.908

Review 2.  Emerging drugs for the treatment of myelofibrosis.

Authors:  Holly L Geyer; Ruben A Mesa
Journal:  Expert Opin Emerg Drugs       Date:  2015-07-08       Impact factor: 4.191

3.  Scientists in the Twitterverse.

Authors:  Neil Savage
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

Review 4.  From Philadelphia-Negative to JAK2-Positive: Effect of Genetic Discovery on Risk Stratification and Management.

Authors:  Naveen Pemmaraju; Alison R Moliterno
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

Review 5.  Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer.

Authors:  Miguel-Angel Perales; Emily K Drake; Naveen Pemmaraju; William A Wood
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

Review 6.  Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.

Authors:  Ayalew Tefferi; Tiziano Barbui
Journal:  Am J Hematol       Date:  2015-02       Impact factor: 10.047

Review 7.  Social Media and Myeloproliferative Neoplasms (MPN)--Focus on Twitter and the Development of a Disease-specific Community: #MPNSM.

Authors:  Naveen Pemmaraju; Vikas Gupta; Ruben Mesa; Michael A Thompson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

8.  Activity, content, contributors, and influencers of the twitter discussion on urologic oncology.

Authors:  Hendrik Borgmann; Stacy Loeb; Johannes Salem; Christian Thomas; Axel Haferkamp; Declan G Murphy; Igor Tsaur
Journal:  Urol Oncol       Date:  2016-03-29       Impact factor: 3.498

Review 9.  Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider.

Authors:  Michael A Thompson; Navneet S Majhail; William A Wood; Miguel-Angel Perales; Mélanie Chaboissier
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

10.  Twitter Social Media is an Effective Tool for Breast Cancer Patient Education and Support: Patient-Reported Outcomes by Survey.

Authors:  Deanna J Attai; Michael S Cowher; Mohammed Al-Hamadani; Jody M Schoger; Alicia C Staley; Jeffrey Landercasper
Journal:  J Med Internet Res       Date:  2015-07-30       Impact factor: 5.428

View more
  9 in total

Review 1.  Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Michael A Thompson; Andrew A Lane
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

2.  Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends.

Authors:  Naveen Pemmaraju; Michael A Thompson; Ruben A Mesa; Tejas Desai
Journal:  J Oncol Pract       Date:  2017-05-17       Impact factor: 3.840

Review 3.  Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine.

Authors:  Deanna J Attai; Patricia F Anderson; Michael J Fisch; David L Graham; Matthew S Katz; Jennifer Kesselheim; Merry Jennifer Markham; Nathan A Pennell; Mina S Sedrak; Michael A Thompson; Audun Utengen; Don S Dizon
Journal:  Semin Hematol       Date:  2017-08-12       Impact factor: 3.851

Review 4.  Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media-#MPNSM.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Jean-Jacques Kiladjian; Ruben Mesa; Michael A Thompson
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

Review 5.  Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN-Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Michael A Thompson; Andrew A Lane
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

6.  Expressed Symptoms and Attitudes Toward Using Twitter for Health Care Engagement Among Patients With Lupus on Social Media: Protocol for a Mixed Methods Study.

Authors:  Alden Bunyan; Swamy Venuturupalli; Katja Reuter
Journal:  JMIR Res Protoc       Date:  2021-05-06

7.  Study protocol: responding to the needs of patients with IgA nephropathy, a social media approach.

Authors:  Matthew P M Graham-Brown; Cristina Vasilica; Tom Oates; Ben Light; Christian Clausner; Apostolos Antonacoloulos; Lydia Y J Chen; Paula Ormandy; Jonathan Barratt
Journal:  Clin Kidney J       Date:  2017-11-23

8.  Monitoring Twitter Conversations for Targeted Recruitment in Cancer Trials in Los Angeles County: Protocol for a Mixed-Methods Pilot Study.

Authors:  Katja Reuter; Praveen Angyan; NamQuyen Le; Alicia MacLennan; Sarah Cole; Ricky N Bluthenthal; Christianne J Lane; Anthony B El-Khoueiry; Thomas A Buchanan
Journal:  JMIR Res Protoc       Date:  2018-09-25

9.  Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience.

Authors:  Siba El Hussein; Joseph D Khoury; Kirill A Lyapichev; Mehrnoosh Tashakori; Mahsa Khanlari; Roberto N Miranda; Rashmi Kanagal-Shamanna; Sa A Wang; Aadil Ahmed; Kamran M Mirza; Genevieve M Crane; L Jeffrey Medeiros; Sanam Loghavi
Journal:  Mod Pathol       Date:  2020-11-20       Impact factor: 7.842

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.